Cara Therapeutics, Inc. 4
4 · Cara Therapeutics, Inc. · Filed Mar 17, 2016
Insider Transaction Report
Form 4
Schoell Josef
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2016-03-16$0.78/sh+8,000$6,240→ 36,000 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-03-16−8,000→ 0 totalExercise: $0.78Exp: 2016-09-29→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2016-03-16$0.85/sh+10,000$8,500→ 46,000 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-03-16−10,000→ 0 totalExercise: $0.85Exp: 2021-09-08→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Immediately exercisable.